The Hospital for Sick Children

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, The Hospital for Sick Children sits in the top decile of US sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count).

23 total trials 8 currently recruiting 7 completed early-phase tilt top decile by trial count

The Hospital for Sick Children: 23 sponsored US clinical trials, 8 recruiting.

The Hospital for Sick Children sponsors 23 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 7 completed. 2 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Growth & Development, with 1 trials.

Top-decile sponsor footprint

The Hospital for Sick Children ranks in the top decile of sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

23 total, page 1 of 1

RECRUITING NA

Sodium Awareness in Lactation Trial

NCT06563726

RECRUITING NA

Bright Ideas - CIN Feasibility Study

NCT04929899

RECRUITING NA

iCanCope With Post-Operative Pain (iCanCope PostOp)

NCT05382962

RECRUITING

Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block

NCT04559425

RECRUITING Phase 2

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

NCT03118986

RECRUITING Phase 3

Simple Bone Cysts in Kids

NCT02193841

RECRUITING

International Rare Histiocytic Disorders Registry (IRHDR)

NCT02285582

RECRUITING

Optimizing Nutrition and Milk (Opti-NuM) Project

NCT06870981

ACTIVE NOT RECRUITING Phase 2

RIC-NEC Randomized Controlled Trial

NCT05279664

ACTIVE NOT RECRUITING Phase 3

Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial

NCT04333823

ACTIVE NOT RECRUITING NA

ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program

NCT04782466

ACTIVE NOT RECRUITING NA

iPeer2Peer Program for Youth With Sickle Cell Disease

NCT03989986

ACTIVE NOT RECRUITING Phase 2

Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)

NCT02840409

NOT YET RECRUITING NA

FIT-ATOMIC Exercise Feasibility Trial

NCT06870968

COMPLETED NA

Symptom Screening Linked to Care Pathways

NCT04614662

COMPLETED Phase 1

COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors

NCT03206021

TERMINATED Phase 1

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

NCT02992964

TERMINATED NA

Yoga Fatigue Study

NCT02134782

COMPLETED Phase 1

Encapsulated Calcium Absorption in Pregnancy

NCT01678079

COMPLETED NA

Adherence in Pediatric Multiple Sclerosis

NCT02234713

COMPLETED

Preventing Cardiac Sequelae in Pediatric Cancer Survivors

NCT01805778

COMPLETED Phase 1

Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours

NCT01135563

COMPLETED Phase 2

A Study Comparing Two Treatments for Infants With Hydrocephalus

NCT00652470

What is open in the The Hospital for Sick Children pipeline

8 recruiting of 23 indexed (35% open); 7 completed (30%).

Phase mix: 2 late (III/IV) vs 8 early (I/II) (early-phase heavy).

Top condition: Growth & Development (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The Hospital for Sick Children: open-pipeline peers nationwide

Peers matched on 23 registered trials and 35% open enrollment, not the therapeutic-area sidebar.

The Hospital for Sick Children sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1520253035 0%10%20%30%40% Total trials Recruiting share The Hospital for Sick ChildrenAMAG PharmaceuticalsAtriCureCara TherapeuticsCraig L Slingluff, JrGiselle ShollerThe University of Texas at ArlingtonStemline TherapeuticsTrustees of Dartmouth College
The Hospital for Sick Children sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The Hospital for Sick Children sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 23 trials (± recruiting share)

Sponsors near 35% open enrollment (± trial volume)

What to do with this The Hospital for Sick Children page

23 registered trials is a research-attention snapshot, not an endorsement of The Hospital for Sick Children or any single study.

  • 8 of The Hospital for Sick Children's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Growth & Development is the condition The Hospital for Sick Children studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Growth & Development trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

The Hospital for Sick Children pipeline card: 23 registered trials from official public datasets.Report a data error.